MedTrace Logo

Financial Toxicity in Breast Cancer Surgery

NCT05104632 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 630

Last updated 2025-06-15

No results posted yet for this study

Summary

The purpose of this study is to evaluate financial toxicity, or financial harm, in breast cancer patients. The study will follow patients throughout their cancer treatment. The study investigators will measure if patients are experiencing financial toxicity and if it changes throughout treatment, and whether it's associated with different cancers, treatments, or demographics. Also, the study investigators will measure if financial toxicity impacts other areas of life (e.g., well-being, satisfaction). Finally, patients will be asked to estimate how much money they expect to spend on out-of-pocket expenses during their treatment and how their finances and employment status have changed since their cancer diagnosis.

Conditions

Sponsors & Collaborators

  • St. Joseph's Healthcare Hamilton

    collaborator OTHER

  • Juravinski Cancer Center

    collaborator OTHER

  • McMaster University

    lead OTHER

Principal Investigators

  • Christopher J Coroneos, MD, MSc · McMaster University

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-18
Primary Completion
2027-02-01
Completion
2027-02-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05104632 on ClinicalTrials.gov